UPPER INTESTINAL SURVEILLANCE IN FAMILIAL ADENOMATOUS POLYPOSIS

被引:44
作者
DEBINSKI, HS
SPIGELMAN, AD
HATFIELD, A
WILLIAMS, CB
PHILLIPS, RKS
机构
[1] ST MARKS HOSP,POLYPOSIS REGISTRY,LONDON EC1V 2PS,ENGLAND
[2] ST MARKS HOSP,IMPERIAL CANC RES FUND,COLORECTAL UNIT,LONDON EC1V 2PS,ENGLAND
[3] MIDDLESEX HOSP,ACAD SURG UNIT,LONDON,ENGLAND
[4] ST MARYS HOSP,ACAD SURG UNIT,LONDON W2 1NY,ENGLAND
关键词
FAMILIAL ADENOMATOUS POLYPOSIS; SURVEILLANCE; ENDOSCOPY; DUODENAL CANCER;
D O I
10.1016/0959-8049(95)00171-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our understanding of the natural history of upper gastrointestinal (GI) involvement in familial adenomatous polyposis (FAP) is still evolving, although we know that the main cause of death after colectomy in FAP is upper GI malignancy, affecting 5% of patients. The aim of duodenal surveillance is to target high risk individuals and identify cancers early. We have screened 200 patients prospectively and have observed that duodenal polyposis progresses slowly, but there are some young people who have severe disease who merit close observation. We pay particular attention to endoscopic technique and histological detail, and use a duodenal staging system. Patients are offered randomisation to studies of chemopreventive agents, and those with advanced disease are considered for surgery. Successful management is inhibited by our deficient knowledge of the natural history of upper gastrointestinal polyposis, and by our inability to identify high risk individuals with histological markers rather than because of any technological deficiencies in endoscopic equipment.
引用
收藏
页码:1149 / 1153
页数:5
相关论文
共 39 条
[21]  
NODA Y, 1992, CANCER, V70, P1847, DOI 10.1002/1097-0142(19921001)70:7<1847::AID-CNCR2820700707>3.0.CO
[22]  
2-C
[23]   IATROGENIC PANCREATITIS IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
NUGENT, KP ;
SPIGELMAN, AD ;
WILLIAMS, CB ;
PHILLIPS, RKS .
GUT, 1993, 34 (09) :1269-1270
[24]   LIFE EXPECTANCY AFTER COLECTOMY AND ILEORECTAL ANASTOMOSIS FOR FAMILIAL ADENOMATOUS POLYPOSIS [J].
NUGENT, KP ;
SPIGELMAN, AD ;
PHILLIPS, RKS .
DISEASES OF THE COLON & RECTUM, 1993, 36 (11) :1059-1062
[25]   RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF SULINDAC ON DUODENAL AND RECTAL POLYPOSIS AND CELL-PROLIFERATION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS [J].
NUGENT, KP ;
FARMER, KCR ;
SPIGELMAN, AD ;
WILLIAMS, CB ;
PHILLIPS, RKS .
BRITISH JOURNAL OF SURGERY, 1993, 80 (12) :1618-1619
[26]   THE RISK OF UPPER GASTROINTESTINAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
OFFERHAUS, GJA ;
GIARDIELLO, FM ;
KRUSH, AJ ;
BOOKER, SV ;
TERSMETTE, AC ;
KELLEY, NC ;
HAMILTON, SR .
GASTROENTEROLOGY, 1992, 102 (06) :1980-1982
[27]   RESTRICTION OF OCULAR FUNDUS LESIONS TO A SPECIFIC SUBGROUP OF APC MUTATIONS IN ADENOMATOUS POLYPOSIS-COLI PATIENTS [J].
OLSCHWANG, S ;
TIRET, A ;
LAURENTPUIG, P ;
MULERIS, M ;
PARC, R ;
THOMAS, G .
CELL, 1993, 75 (05) :959-968
[28]  
PARK JG, 1992, P ANN M AM SOC CLIN, P11
[29]   IDENTICAL APC EXON-15 MUTATIONS RESULT IN A VARIABLE PHENOTYPE IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
PAUL, P ;
LETTEBOER, T ;
GELBERT, L ;
GRODEN, J ;
WHITE, R ;
COPPES, MJ .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :925-931
[30]   GARDNER SYNDROME AND PERIAMPULLARY MALIGNANCY [J].
PAULI, RM ;
PAULI, ME ;
HALL, JG .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1980, 6 (03) :205-219